Advertisement
Screener

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

1.8 / 5 stars · 41/112 Roast Me

NATURE’S SUNSHINE PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-10.

Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2021-03-10

  • NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
  • NATURE’S SUNSHINE PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 25.00K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month
2020-12-310.00 shares
10-K · filed 2021-03-10
2019-12-3125.00K shares
10-K · filed 2021-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01